Highland Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Highland Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$58.92 - $84.67 $14,199 - $20,405	-241 Reduced 0.85%	28,211 $1.75 Million
Q1 2022 Apr 19, 2022	SELL	$86.42 - $109.81 $35,345 - $44,912	-409 Reduced 1.42%	28,452 $2.99 Million
Q4 2021 Jan 28, 2022	SELL	$98.56 - $119.91 $66,626 - $81,059	-676 Reduced 2.29%	28,861 $3.11 Million
Q3 2021 Oct 25, 2021	SELL	$91.91 - $110.37 $237,679 - $285,416	-2,586 Reduced 8.05%	29,537 $3.24 Million
Q2 2021 Jul 30, 2021	SELL	$86.24 - $95.92 $150,661 - $167,572	-1,747 Reduced 5.16%	32,123 $3.01 Million
Q1 2021 Apr 27, 2021	SELL	$71.83 - $95.48 $95,749 - $127,274	-1,333 Reduced 3.79%	33,870 $3.12 Million
Q4 2020 Jan 21, 2021	SELL	$67.0 - $84.39 $145,792 - $183,632	-2,176 Reduced 5.82%	35,203 $2.58 Million
Q3 2020 Oct 16, 2020	BUY	$55.23 - $79.93 $62,520 - $90,480	1,132 Added 3.12%	37,379 $2.9 Million
Q2 2020 Jul 22, 2020	SELL	$30.2 - $56.98 $107,753 - $203,304	-3,568 Reduced 8.96%	36,247 $2.02 Million
Q1 2020 May 05, 2020	SELL	$24.87 - $38.56 $78,713 - $122,042	-3,165 Reduced 7.36%	39,815 $1.18 Million
Q4 2019 Feb 05, 2020	BUY	$25.43 - $36.67 $1.09 Million - $1.58 Million	42,980 New	42,980 $1.56 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.